SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]
SEC Accession No. 0000895345-23-000502
Filing Date
2023-08-16
Accepted
2023-08-16 16:28:46
Documents
2
Group Members
AARON I. DAVISBOXER ASSET MANAGEMENT INC.BRASLYN LTD.CHRISTOPHER FUGLESANGJOE LEWISLOCKEND FIVE, LLCMVA INVESTORS, LLCSHEHAN B. DISSANAYAKE

Document Format Files

Seq Description Document Type Size
1 ff2392491_13da17-mirati.htm SC 13D/A 368089
2 ff2392491_13da17-ex1.htm EX-1 27671
  Complete submission text file 0000895345-23-000502.txt   397479
Mailing Address 12860 EL CAMINO REAL SUITE 300 SAN DIEGO CA 92130
Business Address 12860 EL CAMINO REAL SUITE 300 SAN DIEGO CA 92130 (858) 400-3112
Boxer Capital, LLC (Filed by) CIK: 0001465837 (see all company filings)

IRS No.: 203828456 | State of Incorp.: DE
Type: SC 13D/A

Mailing Address 3545 CRAY COURT SAN DIEGO CA 92121
Business Address 3545 CRAY COURT SAN DIEGO CA 92121 858-332-3410
Mirati Therapeutics, Inc. (Subject) CIK: 0001576263 (see all company filings)

IRS No.: 462693615 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13D/A | Act: 34 | File No.: 005-87670 | Film No.: 231178546
SIC: 2834 Pharmaceutical Preparations